TGS1 impacts snRNA 3′-end processing, ameliorates survival motor neuron-dependent neurological phenotypes in vivo and prevents neurodegeneration
Roake, Caitlin M.
Kobin, Marie A.
Tartaglia, Gian Gaetano
De Pittà, Cristiano
Di Schiavi, Elia
Artandi, Steven E.
Raffa, Grazia D.
GroupLu Chen Lab (Temple University)
Fox Chase Cancer Center
DepartmentCancer and Cellular Biology
Permanent link to this recordhttp://hdl.handle.net/20.500.12613/9083
MetadataShow full item record
AbstractTrimethylguanosine synthase 1 (TGS1) is a highly conserved enzyme that converts the 5′-monomethylguanosine cap of small nuclear RNAs (snRNAs) to a trimethylguanosine cap. Here, we show that loss of TGS1 in Caenorhabditis elegans, Drosophila melanogaster and Danio rerio results in neurological phenotypes similar to those caused by survival motor neuron (SMN) deficiency. Importantly, expression of human TGS1 ameliorates the SMN-dependent neurological phenotypes in both flies and worms, revealing that TGS1 can partly counteract the effects of SMN deficiency. TGS1 loss in HeLa cells leads to the accumulation of immature U2 and U4atac snRNAs with long 3′ tails that are often uridylated. snRNAs with defective 3′ terminations also accumulate in Drosophila Tgs1 mutants. Consistent with defective snRNA maturation, TGS1 and SMN mutant cells also exhibit partially overlapping transcriptome alterations that include aberrantly spliced and readthrough transcripts. Together, these results identify a neuroprotective function for TGS1 and reinforce the view that defective snRNA maturation affects neuronal viability and function.
CitationChen L, Roake CM, Maccallini P, Bavasso F, Dehghannasiri R, Santonicola P, et al. TGS1 impacts snRNA 3′-end processing, ameliorates survival motor neuron-dependent neurological phenotypes in vivo and prevents neurodegeneration, Nucleic Acids Res. 2022 Nov 28;50(21):12400–12424. doi:10.1093/nar/gkac659.
Citation to related workOxford University Press
Has partNucleic Acids Research, Vol. 50, Iss. 21
ADA complianceFor Americans with Disabilities Act (ADA) accommodation, including help with reading this content, please contact firstname.lastname@example.org
Except where otherwise noted, this item's license is described as Attribution-NonCommercial CC BY-NC